Germany’s Formycon and its licensing partner Klinge Biopharma have announced that the European Commission (EC) has granted ...

EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / ...

Regulatory ApprovalFormycon receives EU approval for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand names AHZANTIVE® and Baiama® 20.01.2025 / 06:30 CET/CESTThe issuer is solely ...

Young nearsighted kids who wear bifocal contact lenses that slow uncoordinated eye growth do not lose the benefits of the ...

Young nearsighted kids who wear bifocal contact lenses that slow uncoordinated eye growth do not lose the benefits of the treatment once they stop ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Summary: New research demonstrates that high-add multifocal contact lenses significantly slow myopia progression in children, with benefits that persist even after discontinuation. The lenses, ...

Myopic Macular Degeneration Market Insight DelveInsight’s Myopic Macular Degeneration Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UN ...

DelveInsight’s Myopic Macular Degeneration Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED ...